At Exogenus Therapeutics, we strive to address unmet needs in the fields of regenerative medicine and inflammatory disorders.
Exo-101, our lead candidate, has been shown in vitro and in vivo to have regenerative, anti‑inflammatory and immunomodulatory properties.